Cargando…
Disease modification and Neuroprotection in neurodegenerative disorders
BACKGROUND: Disease modifying therapies (DMTs) are urgently needed for neurodegenerative diseases (NDD) such as Alzheimer’s disease (AD) and many other disorders characterized by protein aggregation and neurodegeneration. Despite advances in understanding the neurobiology of NDD, there are no approv...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613313/ https://www.ncbi.nlm.nih.gov/pubmed/29021896 http://dx.doi.org/10.1186/s40035-017-0096-2 |